What is LOPJLB’s current signal on ALDX?

LOPJLB’s latest quantitative signal on Aldeyra The (ALDX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ALDX in?

Aldeyra The (ALDX) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Aldeyra The based / listed?

Aldeyra The is based in US, listed on NASDAQ.

Aldeyra The (ALDX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.95-1.04%Close

SELLCRISIS · day 11

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $57M
Beta: 1.20
P/E (TTM): -2.37
IV-%ile: 49

IV ATM: 164.3%
Short % float: 6.84%
Days to cover: 4.9
SI change: +15.5%

1W: -26.36%
1M: -36.67%

vs SPY 1W: -27.91%
vs SPY 1M: -38.43%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of…

Employees: 6
Headquarters: US
Founded: 2014
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 60.3M
Float: 87.3%

aldeyra.com ↗

Key executives

Todd C. Brady — Chief Executive Officer, President & Director

Michael Alfieri — Head of Finance and Principal Financial & Accounting Officer

Laura Nichols — Operations Manager

SEC filings

EDGAR · CIK 13412350 · ALDX

Analyst consensus

Buy

Bullish1894.7%

Neutral15.3%

Bearish00.0%

L $7.00Avg $9.67H $12.00

Target$9.67+917.89%

Last$0.95

Key stats

Industry peers

Prediction markets

Company news